Galmed Pharmaceuticals
GLMD
GLMD
34 hedge funds and large institutions have $50.9M invested in Galmed Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
16% less capital invested
Capital invested by funds: $60.6M → $50.9M (-$9.66M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $74K
Holders
34
Holding in Top 10
–
Calls
–
Puts
$74K
Top Buyers
| 1 | +$630K | |
| 2 | +$572K | |
| 3 | +$420K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$196K |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$71.9K |
Top Sellers
| 1 | -$339K | |
| 2 | -$147K | |
| 3 | -$138K | |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$106K |
| 5 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
-$97.9K |